Skip to content

Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With Aging

Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With Aging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07814235
Enrollment
45
Registered
2026-09-10
Start date
2026-06-10
Completion date
2027-09-30
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Assisted Reproduction Technologies, Epigenetic Aging, Infertility, Male Fertility

Keywords

infertility, cryopreservation, sperm, semen, semen analysis, DNA methylation, epigenetics, assisted reproductive technology

Brief summary

This observational study will evaluate whether sperm cryopreservation can help preserve sperm quality and molecular characteristics that may be affected by increasing paternal age. Men aged 18 years and older will provide a semen sample and a blood sample for laboratory analysis. Each semen sample will be divided into fresh, slow-frozen, and vitrified aliquots. The study will compare sperm quality (as assessed by computer-assisted sperm analysis), DNA methylation profiles, DNA fragmentation, sperm telomere length before and after cryopreservation. The effects of age on these parameters will also be assessed. The impact of age on seminal plasma extracellular vesicle composition and blood cell telomere length will also be analysed. The goal is to determine whether sperm cryopreservation may represent a strategy for preserving sperm characteristics associated with younger paternal age.

Detailed description

The aging process is associated with declining fertility and increased risks of adverse reproductive and offspring health outcomes. Although the effects of maternal age have been extensively studied, the impact of paternal aging on sperm quality, reproductive outcomes, and molecular characteristics of sperm remains incompletely understood. The primary objective of this study is to evaluate whether sperm cryopreservation may serve as an alternative to the use of sperm collected at older ages in assisted reproduction treatments. The primary endpoint is the difference in sperm DNA methylation patterns between fresh ejaculated samples and samples subjected to cryopreservation. Cryopreservation will be considered a potentially valid strategy if DNA methylation patterns remain substantially preserved following the cryopreservation process. At least 45 male participants will be recruited and grouped according to age. Participants will provide one semen sample and a peripheral blood sample. Following routine semen analysis, each semen sample will be divided into three aliquots: fresh, slow-frozen, and vitrified. Cryopreserved aliquots will be stored in liquid nitrogen and subsequently thawed or warmed for analysis. Standard semen parameters, including volume, concentration, motility, sperm kinetics, and morphology, will be evaluated. Additional analyses will include sperm DNA methylation, DNA fragmentation, telomere length, and characterization of extracellular vesicles and their composition. Identical assessments will be performed on fresh and cryopreserved samples to compare the effects of slow freezing and vitrification. Secondary objectives include evaluating age-related differences in semen quality and molecular biomarkers, identifying markers associated with biological gamete age, characterizing age-related differences in seminal extracellular vesicles, and exploring associations between sperm molecular characteristics and lifestyle. Participants will also complete validated questionnaires regarding lifestyle and dietary habits.

Interventions

None listed

Sponsors

IVI Murcia
Lead SponsorOTHER
European Union
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male participants aged 18 to 65 years * Attending IVI Murcia for semen analysis and/or assisted reproduction treatment * Able and willing to provide written informed consent * Willing to provide a semen sample and a blood sample for research purposes

Exclusion criteria

* Previous diagnosis of azoospermia or severe oligozoospermia (sperm concentration \<1 million sperm/mL) * Known chromosomal abnormality (abnormal karyotype) * Known Y chromosome microdeletion * Febrile illness within the previous 3 months * Presence of varicocele * Current use of vitamin or antioxidant supplements intended to improve semen quality

Design outcomes

Primary

MeasureTime frameDescription
Sperm DNA methylation profileBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).DNA methylation levels of a predefined nine-gene panel measured by pyrosequencing with duplicate measurements and compared between fresh, slow-frozen, and vitrified sperm samples.

Secondary

MeasureTime frameDescription
Sperm concentrationBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).Sperm concentration (million sperm/mL) measured using computer-assisted sperm analysis (CASA).
Total sperm motilityBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).Percentage of motile sperm measured using CASA.
Progressive sperm motilityBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).Percentage of progressively motile sperm measured using computer-assisted sperm analysis (CASA).
Normal sperm morphologyBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).Percentage of sperm with normal morphology assessed by microscopic evaluation of stained slides according to World Health Organization (WHO) criteria.
Sperm DNA fragmentationBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).DNA fragmentation measured in fresh, slow-frozen, and vitrified sperm samples.
Sperm telomere lengthBaseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).Sperm telomere length measured in fresh, slow-frozen, and vitrified sperm samples.
Seminal plasma extracellular vesicle compositionBaseline (study semen collection visit).Characterization of seminal plasma extracellular vesicle composition in fresh semen samples.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026